Clinical trialNCT02611700UnknownPhase 3Interventional

Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

SponsorBiotech Pharmaceutical Co., Ltd.Enrollment504Esophageal Squamous Cell Carcinomas

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lin Shen, Dr
Peking University Cancer Hospital & Institute
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Anhui Provincial Hospital
Hefei, Anhui, China
Bin Hu
Not, yet, recruiting
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Jing Huang
Not, yet, recruiting
Chinese Pla General Hospital Medical School of Chinese Pla
Beijing, Beijing Municipality, China
Guanghai DaiQuanli Han
Not, yet, recruiting
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Chunmei BaiNing Jia
Not, yet, recruiting
the 307 Hospital of Chinese People'S Liberation Army
Beijing, Beijing Municipality, China
Jianming XuYuling Chen
Not, yet, recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China
Cheng HuangWu Zhuang
Not, yet, recruiting
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Xiaoyan Lin
Not, yet, recruiting
Sun Yat-Sen University Cancer Center Sun Yat-Sen University Cancer Hospital
Guangzhou, Guangdong, China
Dongsheng ZhangRuihua Xu
Recruiting
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
Yingcheng Lin
Not, yet, recruiting
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Xiaoli WeiYuxian Bai
Not, yet, recruiting
the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Liuxing WangQingxia FanWang Ma
Not, yet, recruiting
Hunan Cancer Hospital
Changsha, Hunan, China
Shaofeng JiangXianliXianli Yin
Not, yet, recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Lianke LiuYongqian Shu
Not, yet, recruiting
Affiliated Hospital ,jiangnan University
Wuxi, Jiangsu, China
Dong HuaYong Mao
Not, yet, recruiting
Jilin Cancer Hospital
Changchun, Jilin, China
Yanrong WangYing Cheng
Not, yet, recruiting
Liaoning Cancer Hospital
Shenyang, Liaoning, China
Tao SunXiaoxin Wang
Not, yet, recruiting
Changhai Hospital of Shanghai
Shanghai, Shanghai Municipality, China
Mei WangQiang Fu
Not, yet, recruiting
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Jun ZhangXinfang Shangguan
Not, yet, recruiting
Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Tianshu LiuYiwei Yu
Not, yet, recruiting
the First Affiliated of Xi'An Communication University
Xi’an, Shanxi, China
Enxiao Li
Not, yet, recruiting
Xijing Hospital
Xi’an, Shanxi, China
Li PengXin Wang
Not, yet, recruiting
West China Hospital,sichuan University
Chengdu, Sichuan, China
Di LuFeng Peng
Not, yet, recruiting
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Jinhuai XueYi Yi
Not, yet, recruiting
Sir Run Run Shaw Hostpital School of Medicine,zhejiang University
Hangzhou, Zhejiang, China
Hongming PanYu Zheng
Not, yet, recruiting
the Second Affiliated Hospital of Zhejiang University School O
Hangzhou, Zhejiang, China
Caixia DongYing Yuan
Not, yet, recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Guangyuan LouYiping Zhang
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2015
Primary completion: 31 Dec 2018
Completion: 30 Jun 2019
Last update posted: 1 Feb 2016
Registered enrollment: 504
Registry id: NCT02611700

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.